Hari Deshpande, MD

Hari Deshpande, MD, located at 20 York Street in New Haven, Connecticut, is a medical institution specializing in the treatment of sarcomas and thyroid cancers. Dr. Deshpande, a medical oncologist, works closely with a team of specialized surgeons, endocrinologists, radiation oncologists, radiologists, pathologists, and nurses to create personalized treatment plans for each patient. With a focus on personalized medicine and the latest molecular techniques, Dr. Deshpande is dedicated to providing the best care possible for his patients.

Dr. Deshpande participates in disease-specific tumor boards and is actively involved in clinical trials for sarcomas and thyroid cancers. He believes that the treatment of these cancers has advanced significantly in recent years, but there is still much more to be done in terms of research and finding effective treatments.

As the director of the Medical Oncology Inpatient Consult Service at Smilow Cancer Hospital, Dr. Deshpande is committed to providing compassionate care for patients at all stages of their cancer journey. From the initial diagnosis to end-of-life care, Dr. Deshpande and his team strive to make the hospital experience as stress-free as possible for patients and their families.

Throat, larynx, mouth, nose, sinuses, soft tissues, and thyroid cancers are among the conditions treated at Hari Deshpande, MD. With a focus on patient-centered care and a dedication to advancing research in the field of oncology, Dr. Deshpande and his team are committed to providing the best possible care for their patients.